MNMD Company Profile and Key Details
Mind Medicine (MindMed) Inc.
MNMD Stock Price Chart
Stock Price Today
Mind Medicine (MindMed) Inc. (MNMD) stock surged +0.35%, trading at $7.18 on NASDAQ, up from the previous close of $7.16. The stock opened at $7.26, fluctuating between $7.05 and $7.48 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Company Information
| Employees | 57 |
| Beta | 2.33 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) stock price is $7.18 in the last trading session. During the trading session, MNMD stock reached the peak price of $7.48 while $7.05 was the lowest point it dropped to. The percentage change in MNMD stock occurred in the recent session was 0.35% while the dollar amount for the price change in MNMD stock was $0.03.
The NASDAQ listed MNMD is part of Biotechnology industry that operates in the broader Healthcare sector. Mind Medicine (MindMed) Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Wong Hu J.D.
Chief Legal Officer & Corporation Sec.
Mr. Leonard Latchman
Co-founder
Dr. Daniel Rollings Karlin M.A., M.D.
Chief Medical Officer
Ms. Carrie F. Liao C.P.A., CGMA
Vice President & Chief Accounting Officer
Mr. Schond L. Greenway
Chief Financial Officer
Dr. Miriam Halperin Wernli Ph.D.
Executive Pres
Mr. Robert Barrow
Chief Executive Officer & Director
Ms. Carrie F. Liao CPA, CGMA
Vice President & Chief Accounting Officer
Dr. Francois P. Lilienthal M.B.A., M.D.
Chief Commercial Officer
Mr. Mark R. Sullivan J.D.
Chief Legal Officer & Corporation Sec.
Dr. Scott M. Freeman M.D.
Co-Founder & Clinical Advisor
Mr. Maxim Jacobs C.F.A.
Vice President of Investor Relations
MNMD's closing price is 105.14% higher than its 52-week low of $3.50 where as its distance from 52-week high of $12.22 is -41.24%.
Number of MNMD employees currently stands at 57.
Official Website of MNMD is: https://www.mindmed.co
MNMD could be contacted at phone 650 208 2454 and can also be accessed through its website. MNMD operates from 1055 West Hastings Street, Vancouver, BC V6E 2E9, Canada.
MNMD stock volume for the day was 1.33M shares. The average number of MNMD shares traded daily for last 3 months was 1.42M.
The market value of MNMD currently stands at $526.52M with its latest stock price at $7.18 and 73.33M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com